ArticleCancer chemotherapy and pharmacology2011

A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies.

Paula M Fracasso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.